Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Erectile dysfunction is linked to marital issues in patients with benign prostatic hyperplasia.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Early intervention for acute urinary retention can reduce costs and improve care.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Chronic pelvic pain after finasteride may need pain education and rehab, not just medical treatments.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Regenerative repair is essential to prevent long-term kidney function issues after obstruction.

It's hard to predict how much worse urinary symptoms will get over time.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.

Older adults on certain medications should be carefully monitored for urinary issues and low sodium levels.